NASDAQ : TVTX
Travere Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 50.57 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 4.77B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Travere Therapeutics, Inc. (TVTX) reported revenue of 591.33M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 591.33M | 490.73M | 233.18M | 145.24M | 109.46M | 131.84M |
| Cost of Revenue | 241.22M | 216.35M | 225.24M | 256.44M | 231.75M | 204.98M |
| Gross Profit | 350.12M | 274.38M | 7.93M | -111.20M | -122.29M | -73.14M |
| Selling, General & Admin | 390.57M | 337.20M | 264.12M | 265.54M | 197.52M | 126.28M |
| Operating Expenses | 390.57M | 337.20M | 264.12M | 265.54M | 197.52M | 126.28M |
| Operating Income | -40.46M | -62.82M | -256.18M | -376.74M | -319.81M | -199.43M |
| Interest Expense | -9.48M | -10.75M | -11.18M | -11.33M | -11.01M | -19.68M |
| Interest & Investment Income | 11.58M | 12.72M | 17.82M | 21.77M | 6.28M | 1.99M |
| Earnings From Equity Investments | -3.40M | |||||
| Currency Exchange Gain (Loss) | -300.00K | -300.00K | -700.00K | 500.00K | 1.40M | 300.00K |
| Other Non Operating Income (Expenses) | -28.42M | 11.87M | 782.00K | 1.09M | -426.00K | -69.00K |
| EBT Excluding Unusual Items | -67.08M | -49.28M | -252.87M | -364.72M | -323.58M | -216.88M |
| Merger & Restructuring Charges | -2.44M | -11.39M | ||||
| Gain (Loss) on Sale of Investments | 10.20K | 10.20K | ||||
| Other Unusual Items | -7.58M | |||||
| Pretax Income | -67.07M | -49.27M | -320.51M | -376.11M | -331.15M | -216.88M |
| Income Tax Expense | 605.00K | 988.00K | 120.00K | 223.00K | 313.00K | 409.00K |
| Earnings From Continuing Operations | -67.68M | -50.26M | -320.63M | -376.33M | -331.47M | -217.29M |
| Earnings From Discontinued Operations | 24.21M | 24.71M | -915.00K | 264.93M | 52.99M | 37.20M |
| Net Income | -43.46M | -25.55M | -321.55M | -111.40M | -278.48M | -180.09M |
| Net Income to Common | -43.46M | -25.55M | -321.55M | -111.40M | -278.48M | -180.09M |
| Shares Outstanding (Basic) | 91.22M | 89.21M | 78.89M | 74.27M | 63.76M | 59.83M |
| Shares Outstanding (Diluted) | 91.22M | 89.21M | 78.89M | 74.27M | 63.76M | 59.83M |
| EPS (Basic) | -0.48 | -0.29 | -4.08 | -1.50 | -4.37 | -3.01 |
| EPS (Diluted) | -0.48 | -0.29 | -4.08 | -1.50 | -4.37 | -3.01 |
| Free Cash Flow | 92.70M | 37.78M | -237.47M | -280.02M | -186.29M | -19.89M |
| Free Cash Flow Per Share | 1.02 | 0.42 | -3.01 | -3.77 | -2.92 | -0.33 |
| Gross Margin | 59.21% | 55.91% | 3.40% | -76.57% | -111.72% | -55.48% |
| Operating Margin | -6.84% | -12.80% | -109.87% | -259.40% | -292.17% | -151.27% |
| Profit Margin | -7.35% | -5.21% | -137.90% | -76.70% | -254.41% | -136.60% |
| Free Cash Flow Margin | 15.68% | 7.70% | -101.84% | -192.80% | -170.19% | -15.09% |
| EBITDA | 22.91M | -2.08M | -212.63M | -338.21M | -299.09M | -186.68M |
| EBITDA Margin | 3.88% | -0.42% | -91.19% | -232.87% | -273.25% | -141.60% |
| D&A For EBITDA | 63.37M | 60.74M | 43.55M | 38.53M | 20.72M | 12.75M |
| EBIT | -40.46M | -62.82M | -256.18M | -376.74M | -319.81M | -199.43M |
| EBIT Margin | -6.84% | -12.80% | -109.87% | -259.40% | -292.17% | -151.27% |
| Revenue as Reported | 591.33M | 490.73M | 233.18M | 145.24M | 109.46M | 131.84M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 117.73M | 93.03M | 58.53M | 58.18M | 61.69M | 165.75M |
| Short-Term Investments | 371.44M | 229.76M | 312.17M | 508.68M | 388.56M | 387.13M |
| Cash & Short-Term Investments | 489.18M | 322.80M | 370.70M | 566.85M | 450.25M | 552.88M |
| Accounts Receivable | 80.64M | 80.13M | 27.12M | 21.18M | 16.65M | 15.91M |
| Other Receivables | 2.30M | 1.30M | 2.30M | 4.60M | 1.90M | 900.00K |
| Receivables | 82.94M | 81.43M | 29.42M | 25.78M | 18.55M | 16.81M |
| Inventory | 7.83M | 5.88M | 6.20M | 9.41M | 4.52M | 7.31M |
| Prepaid Expenses | 35.19M | 27.46M | 10.38M | 14.73M | 10.13M | 5.82M |
| Other Current Assets | 2.99M | |||||
| Total Current Assets | 615.14M | 437.56M | 416.70M | 616.77M | 486.44M | 582.83M |
| Property, Plant & Equipment | 11.98M | 14.60M | 19.63M | 25.54M | 30.05M | 34.30M |
| Goodwill | 753.00K | 753.00K | 753.00K | 753.00K | 753.00K | 936.00K |
| Other Intangible Assets | 130.76M | 113.11M | 103.22M | 103.69M | 96.32M | 147.50M |
| Other Long-Term Assets | 40.73M | 39.16M | 53.82M | 42.16M | 59.03M | 11.07M |
| Total Assets | 799.36M | 605.19M | 594.12M | 788.91M | 672.59M | 776.63M |
| Accounts Payable | 7.50M | 24.80M | 23.53M | 41.67M | 17.29M | 15.14M |
| Accrued Expenses | 136.27M | 126.03M | 86.03M | 107.57M | 95.74M | 75.18M |
| Current Portion of Long-Term Debt | 68.68M | |||||
| Current Portion of Leases | 6.16M | 5.88M | 5.41M | 4.91M | 4.43M | 3.91M |
| Current Unearned Revenue | 2.81M | 7.10M | 11.98M | 16.27M | ||
| Other Current Liabilities | 2.10M | 3.19M | 14.29M | 16.66M | 12.72M | 13.59M |
| Total Current Liabilities | 152.03M | 159.90M | 200.75M | 177.91M | 142.16M | 124.09M |
| Long-Term Debt | 602.78M | 311.72M | 310.31M | 377.26M | 375.55M | 226.58M |
| Long-Term Leases | 7.96M | 11.13M | 17.19M | 22.61M | 27.51M | 31.50M |
| Long-Term Unearned Revenue | 1.83M | 10.93M | 20.38M | |||
| Other Long-Term Liabilities | 12.07M | 7.60M | 6.80M | 8.48M | 73.58M | 71.98M |
| Total Liabilities | 774.84M | 490.36M | 535.05M | 588.10M | 629.73M | 474.52M |
| Common Stock | 9.00K | 9.00K | 9.00K | 7.00K | 6.00K | 6.00K |
| Additional Paid-In Capital | 1.57B | 1.59B | 1.51B | 1.33B | 1.06B | 1.07B |
| Retained Earnings | -1.54B | -1.47B | -1.45B | -1.13B | -1.01B | -765.97M |
| Comprehensive Income & Other | -1.12M | -1.19M | -80.00K | -1.46M | -2.91M | -562.00K |
| Shareholders' Equity | 24.52M | 114.83M | 59.08M | 200.81M | 42.85M | 302.11M |
| Total Liabilities & Equity | 799.36M | 605.19M | 594.12M | 788.91M | 672.59M | 776.63M |
| Total Debt | 616.90M | 328.73M | 401.58M | 404.78M | 407.49M | 261.99M |
| Net Cash (Debt) | -127.73M | -5.94M | -30.88M | 162.07M | 42.76M | 290.90M |
| Net Cash Per Share | -1.40 | -0.07 | -0.39 | 2.18 | 0.67 | 4.86 |
| Filing Date Shares Outstanding | 94.26M | 92.24M | 88.74M | 76.10M | 64.74M | 63.21M |
| Total Common Shares Outstanding | 94.17M | 90.92M | 87.45M | 75.37M | 64.29M | 62.49M |
| Working Capital | 463.12M | 277.66M | 215.95M | 438.87M | 344.27M | 458.74M |
| Book Value Per Share | 0.26 | 1.26 | 0.68 | 2.66 | 0.67 | 4.83 |
| Tangible Book Value | -107.00M | 960.00K | -44.90M | 96.37M | -54.22M | 153.68M |
| Tangible Book Value Per Share | -1.14 | 0.01 | -0.51 | 1.28 | -0.84 | 2.46 |
| Machinery | 5.13M | 4.72M | 5.06M | 4.99M | 4.73M | |
| Construction In Progress | 169.00K | 77.00K | 631.00K | |||
| Leasehold Improvements | 8.99M | 9.37M | 9.69M | 9.18M | 8.79M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -43.46M | -25.55M | -321.55M | -111.40M | -278.48M | -180.09M |
| Depreciation & Amortization | 63.37M | 60.74M | 43.55M | 38.53M | 20.72M | 12.75M |
| Other Amortization | 1.64M | 1.64M | 1.73M | 1.72M | 1.62M | 11.24M |
| Asset Writedown & Restructuring Costs | 65.20M | |||||
| Loss (Gain) From Sale of Investments | -4.44M | -4.44M | -4.54M | -7.46M | -700.00K | 2.01M |
| Stock-Based Compensation | 60.66M | 44.87M | 36.91M | 44.25M | 38.14M | 29.57M |
| Other Operating Activities | 16.21M | -25.49M | 11.68M | -265.52M | -43.02M | -32.48M |
| Change in Accounts Receivable | -16.92M | -27.82M | -6.00M | -11.26M | -1.06M | 853.00K |
| Change in Inventory | -2.08M | 5.02M | -3.77M | -39.42M | -1.21M | 117.00K |
| Change in Accounts Payable | -12.07M | -85.00K | -17.56M | 24.76M | 2.06M | 2.47M |
| Change in Unearned Revenue | -2.81M | -6.12M | -15.78M | -12.93M | 38.30M | |
| Change in Income Taxes | 849.00K | 849.00K | -41.00K | -35.00K | -374.00K | 17.10M |
| Change in Other Net Operating Assets | 28.94M | 10.86M | -29.53M | 16.26M | 14.39M | 21.94M |
| Operating Cash Flow | 92.70M | 37.78M | -237.47M | -280.02M | -186.29M | -14.79M |
| Capital Expenditures | -5.10M | |||||
| Sale (Purchase) of Intangibles | -77.54M | -58.16M | -101.21M | -41.59M | -28.37M | -19.05M |
| Investment in Securities | -125.22M | 86.45M | 200.58M | -109.37M | -3.40M | -113.47M |
| Other Investing Activities | -232.00K | -404.00K | -40.00K | 206.73M | -791.00K | |
| Investing Cash Flow | -202.99M | 27.89M | 99.33M | 55.78M | -32.55M | -137.62M |
| Long-Term Debt Issued | 316.25M | |||||
| Long-Term Debt Repaid | -68.90M | -211.32M | ||||
| Net Debt Issued (Repaid) | 105.21M | -68.90M | 104.93M | |||
| Issuance of Common Stock | 66.22M | 37.54M | 141.52M | 197.60M | 27.11M | 239.89M |
| Other Financing Activities | -18.37M | -2.10M | -2.10M | 21.15M | -14.46M | -8.20M |
| Financing Cash Flow | 153.06M | -33.47M | 139.42M | 218.75M | 117.57M | 231.68M |
| Foreign Exchange Rate Adjustments | -194.00K | 2.29M | -913.00K | 1.98M | -2.79M | 1.71M |
| Net Cash Flow | 42.58M | 34.50M | 359.00K | -3.51M | -104.06M | 80.98M |
| Free Cash Flow | 92.70M | 37.78M | -237.47M | -280.02M | -186.29M | -19.89M |
| Free Cash Flow Margin | 15.68% | 7.70% | -101.84% | -192.80% | -170.19% | -15.09% |
| Free Cash Flow Per Share | 1.02 | 0.42 | -3.01 | -3.77 | -2.92 | -0.33 |
| Levered Free Cash Flow | -18.25M | -38.30M | -228.53M | -178.11M | -163.35M | -60.79M |
| Unlevered Free Cash Flow | -13.97M | -33.22M | -223.27M | -172.74M | -158.08M | -59.73M |
| Cash Interest Paid | 8.84M | 8.84M | 8.84M | 8.84M | 10.16M | 7.33M |
| Cash Income Tax Paid | 996.00K | -16.42M | ||||
| Change in Working Capital | -1.29M | -14.00M | -63.02M | -25.48M | 875.00K | 80.78M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 4.62B | 3.42B | 1.52B | 675.56M | 1.35B | 1.90B |
| Enterprise Value | 4.75B | 3.49B | 1.64B | 446.40M | 1.25B | 1.61B |
| Last Close Price | 50.39 | 38.21 | 17.42 | 8.99 | 21.03 | 31.04 |
| Forward PE | 13.31 | 38.08 | 42.85 | 42.85 | 42.85 | 42.85 |
| PS Ratio | 8.09 | 6.97 | 6.50 | 4.65 | 12.33 | 14.41 |
| PB Ratio | 193.52 | 29.77 | 25.66 | 3.36 | 31.49 | 6.29 |
| P/TBV Ratio | 3,561.18 | 7.01 | 12.37 | |||
| P/FCF Ratio | 51.62 | 90.48 | ||||
| P/OCF Ratio | 51.62 | 90.48 | ||||
| PEG Ratio | 2.20 | 2.20 | 2.20 | 2.20 | 2.20 | |
| EV/Sales Ratio | 8.31 | 7.12 | 7.04 | 3.07 | 11.43 | 12.21 |
| EV/FCF Ratio | 53.00 | 92.47 | ||||
| Debt / Equity Ratio | 25.16 | 2.86 | 6.80 | 2.02 | 9.51 | 0.87 |
| Debt / EBITDA Ratio | 22.59 | 141.76 | ||||
| Debt / FCF Ratio | 6.66 | 8.70 | ||||
| Net Debt / Equity Ratio | 5.21 | 0.05 | 0.52 | -0.81 | -1.00 | -0.96 |
| Net Debt / EBITDA Ratio | 5.57 | -2.85 | -0.14 | 0.48 | 0.14 | 1.56 |
| Net Debt / FCF Ratio | 1.38 | 0.16 | -0.13 | 0.58 | 0.23 | 14.62 |
| Asset Turnover | 0.87 | 0.82 | 0.34 | 0.20 | 0.15 | 0.19 |
| Inventory Turnover | 40.45 | 35.83 | 28.86 | 36.81 | 39.16 | 27.48 |
| Quick Ratio | 3.76 | 2.53 | 1.99 | 3.33 | 3.30 | 4.59 |
| Current Ratio | 4.05 | 2.74 | 2.08 | 3.47 | 3.42 | 4.70 |
| Return on Equity (ROE) | -236.36% | -57.80% | -246.75% | -308.90% | -192.18% | -84.66% |
| Return on Assets (ROA) | -3.73% | -6.55% | -23.15% | -32.22% | -27.58% | -18.01% |
| Return on Capital Employed (ROCE) | -6.20% | -14.10% | -65.10% | -61.70% | -60.30% | -30.60% |
| Earnings Yield | -0.97% | -0.75% | -21.21% | -16.49% | -20.64% | -9.48% |
| FCF Yield | 1.94% | 1.10% | -15.66% | -41.45% | -13.80% | -1.05% |
| Buyback Yield / Dilution | -7.89% | -13.08% | -6.22% | -16.48% | -6.56% | -25.86% |